Noémi is experienced in economic models, model adaptations, preparing health economic dossiers for reimbursement submission in various countries, and has conducted systematic reviews in several disease areas and policy issues.
Noémi has worked on cost-effectiveness models in rheumatology, oncology, cardiology, pain and dermatology; budget impact models; econometric analyses of retrospective databases; quality of life studies; physician surveys; cost-of-illness studies; and on the design of retrospective studies in different disease areas. She has taken part in guideline development for economic evaluation and for reimbursement process. Her therapeutic work areas include oncology (e.g., hepatocellular carcinoma, breast cancer, colorectal cancer), autoimmune disorders (e.g., ankylosing spondylitis and multiple sclerosis), cardiology (e.g., atrial fibrillation, aneurysm), reflux disease, asthma and schizophrenia.
Prior to her current role, Noémi was a health economics manager at AstraZeneca in Hungary. She has presented studies at international clinical and health economic conferences and is the co-author of published, peer-reviewed articles. She received a bachelor’s in economics; a master’s in public economics from the Budapest University of Economic Sciences, Hungary; and a master’s in health economics from the University of York, U.K.